X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1462) 1462
Publication (70) 70
Book Chapter (7) 7
Magazine Article (4) 4
Newspaper Article (4) 4
Conference Proceeding (3) 3
Book Review (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (787) 787
female (540) 540
male (490) 490
risk factors (459) 459
middle aged (359) 359
aged (301) 301
adult (258) 258
diabetes (247) 247
risk (221) 221
cardiovascular disease (217) 217
mortality (214) 214
endocrinology & metabolism (207) 207
obesity (193) 193
cardiovascular diseases (185) 185
body mass index (184) 184
cardiac & cardiovascular systems (175) 175
abridged index medicus (168) 168
research (151) 151
epidemiology (143) 143
prospective studies (135) 135
coronary-heart-disease (132) 132
diabetes mellitus (132) 132
peripheral vascular disease (130) 130
medicine, general & internal (129) 129
type 2 diabetes (127) 127
analysis (119) 119
cardiovascular-disease (116) 116
health aspects (114) 114
blood pressure (112) 112
c-reactive protein (110) 110
studies (110) 110
disease (107) 107
biomarkers - blood (102) 102
health risk assessment (102) 102
association (97) 97
medicin och hälsovetenskap (94) 94
medical and health sciences (92) 92
cholesterol (91) 91
pregnancy (91) 91
inflammation (89) 89
insulin-resistance (89) 89
cohort studies (88) 88
insulin resistance (88) 88
metaanalysis (88) 88
internal medicine (87) 87
aged, 80 and over (83) 83
risk assessment (83) 83
prevention (82) 82
heart failure (80) 80
population (80) 80
cardiovascular diseases - epidemiology (79) 79
atherosclerosis (77) 77
myocardial-infarction (77) 77
medicine (76) 76
follow-up studies (75) 75
incidence (74) 74
prognosis (72) 72
insulin (70) 70
glucose (69) 69
coronary heart disease (68) 68
genetics (68) 68
prevalence (68) 68
risk-factors (68) 68
cardiovascular diseases - blood (67) 67
women (67) 67
adults (66) 66
clinical medicine (66) 66
hypertension (66) 66
lipids (65) 65
medical research (65) 65
cardiovascular (63) 63
biomarkers (62) 62
blood-pressure (62) 62
age (60) 60
physiological aspects (60) 60
united kingdom - epidemiology (60) 60
care and treatment (59) 59
mellitus (58) 58
cardiovascular diseases - etiology (57) 57
diabetes mellitus, type 2 - epidemiology (57) 57
klinisk medicin (57) 57
metabolic syndrome (57) 57
diagnosis (56) 56
cardiovascular diseases - prevention & control (55) 55
stroke (55) 55
adolescent (54) 54
cross-sectional studies (54) 54
health risks (54) 54
exercise (53) 53
metabolism (53) 53
research article (53) 53
statins (53) 53
treatment outcome (53) 53
clinical trials (52) 52
heart diseases (51) 51
time factors (51) 51
age factors (50) 50
complications and side effects (50) 50
diabetes mellitus, type 2 - complications (50) 50
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes Care, ISSN 0149-5992, 09/2008, Volume 31, Issue 9, pp. 1898 - 1904
Metabolic Syndrome and Incident Diabetes Current state of the evidence Earl S. Ford , MD, MPH 1 , Chaoyang Li , MD, PHD 1 and Naveed Sattar , MD, PHD 2 1... 
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2016, Volume 37, Issue 39, pp. 2990 - 2992
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9677, pp. 1765 - 1772
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2017, Volume 69, Issue 21, pp. 2646 - 2656
Abstract Recently, treatment with 2 newer classes of type 2 diabetes drugs were found to reduce events in patients with diabetes and cardiovascular (CV)... 
Cardiovascular | Internal Medicine | blood glucose | cardiovascular disease | heart failure | outcomes | hypoglycemic agents | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | MYOCARDIAL-INFARCTION | SAFETY | HEART-FAILURE | SECONDARY ANALYSIS | RISK | MELLITUS | GLUCOSE | ROSIGLITAZONE | Cardiovascular Diseases - complications | Diabetes Mellitus, Type 2 - blood | Survival Rate - trends | Global Health | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Cardiovascular Diseases - mortality | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - pharmacology | Heart failure | Type 2 diabetes | Diabetics | Peptides | Mortality | Glycosylated hemoglobin | Glucose | Heart attack | Dextrose | Cardiac patients | Hypoglycemic agents | Research institutes | Drug therapy | Cardiology | Diabetes therapy | Myocardial infarction | Heart | Glucagon | Cardiovascular disease | Risk factors | Incidence | Urinary bladder | Failure analysis | Blood pressure | Inhibition | Glibenclamide | Cerebral infarction | Abnormalities | FDA approval | Gene expression | Insulin | Body weight gain | Disease prevention | Inhibitors | Biomarkers | Death | Titration | Clinical medicine | Acute coronary syndromes | Health risk assessment | Burns | Cardiovascular diseases | Risk management | Circulation | Kidney transplantation | Drugs | Intervention | Warning | Renal function | Clinical trials | Boundaries | Congestive heart failure | Guidelines | Prevention | Glucose metabolism | Biological effects | Reduction | Calcium-binding protein | Safety | Heart diseases | Age | Stroke | Complications | Diabetes mellitus | Health risks | Tools | Pharmacology | Coronary artery disease | Biological activity | Fractures | Diabetes | Ventricle | Cancer
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 70, Issue 6, pp. 704 - 712
Abstract Background Sodium glucose co-transporter 2 (SGLT2) inhibitors may reduce cardiovascular and heart failure risk in patients with type 2 diabetes... 
Cardiovascular | Internal Medicine | high-sensitivity troponin | galectin-3 | N-terminal pro–B-type natriuretic peptide | cardiovascular stress | sodium glucose co-transporter 2 inhibitor | soluble ST2 | CARDIAC & CARDIOVASCULAR SYSTEMS | RATIONALE | RISK | MELLITUS | BASE-LINE CHARACTERISTICS | HEART | DISEASE | HYPOTHESIS | PLACEBO-CONTROLLED TRIAL | INHIBITORS | N-terminal pro-B-type natriuretic peptide | EMPAGLIFLOZIN | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Male | Biomarkers - blood | Troponin I - blood | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Time Factors | Canagliflozin - therapeutic use | Peptide Fragments - blood | Aged, 80 and over | Cardiovascular Diseases - blood | Female | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Diabetes Mellitus, Type 2 - complications | Natriuretic Peptide, Brain - blood | Type 2 diabetes | Medical research | Analysis | Cardiac patients | Medicine, Experimental | Glucose | Biological markers | Dextrose | Natriuretic peptides | Glucose transporter | Heart failure | Heart | Brain natriuretic peptide | Heart attacks | Peptides | Diabetes mellitus | Health risks | Cardiovascular disease | Galectin-3 | Patients | Troponin | Inhibitors | Troponin I | Sodium | Older people | Calcium-binding protein | Biomarkers | Adults | Diabetes | Cardiovascular diseases | Heart diseases | Age
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 375, Issue 9716, pp. 735 - 742
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 15, pp. 1407 - 1418
Patients with type 1 or type 2 diabetes in Sweden were studied to examine trends in mortality and cardiovascular disease incidence between 1998 and 2014. Both... 
POPULATION | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | HEART-FAILURE | MULTIFACTORIAL INTERVENTION | COMPLICATIONS | PEOPLE | TRENDS | ASSOCIATION | BLOOD-PRESSURE | Cardiovascular Diseases - etiology | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Mortality - trends | Diabetes Mellitus, Type 1 - complications | Sweden - epidemiology | Incidence | Diabetes Mellitus, Type 1 - mortality | Diabetes Mellitus, Type 2 - mortality | Hospitalization - trends | Adolescent | Age of Onset | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Adult | Female | Registries | Aged | Diabetes Mellitus, Type 2 - complications | Complications and side effects | Usage | Mortality | Analysis | Distribution | Event history analysis | Diabetes | Cardiovascular diseases | Heart failure | Heart attacks | Diabetes mellitus | Cardiovascular disease | Diabetes mellitus (insulin dependent) | Metabolism | Patients | Coronary artery disease | Studies | Insulin resistance | Death | Trends | Diabetes mellitus (non-insulin dependent) | Heart diseases | Age | Cardiovascular Diseases | Kardiologi | epidemiology | Sweden | Endokrinologi och diabetes | Type 2 | trends | Endocrinology and Diabetes | Type 1 | complications | Hospitalization | Diabetes Mellitus | etiology | Cardiac and Cardiovascular Systems | mortality
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 7, pp. 633 - 644
In an observational study, patients with type 2 diabetes who had glycated hemoglobin, LDL cholesterol, albuminuria, and blood pressure in target ranges and did... 
MEDICINE, GENERAL & INTERNAL | GLYCEMIA | HYPERGLYCEMIA | MANAGEMENT | DISEASE | MULTIFACTORIAL INTERVENTION | MICROVASCULAR OUTCOMES | FOLLOW-UP | COMPLICATIONS | MELLITUS | ASSOCIATION | Body Mass Index | Glycated Hemoglobin A - analysis | Albuminuria - complications | Cardiovascular Diseases - etiology | Myocardial Infarction - epidemiology | Humans | Middle Aged | Risk Factors | Male | Sweden - epidemiology | Diabetes Mellitus, Type 2 - blood | Smoking - epidemiology | Diabetes Mellitus, Type 2 - mortality | Cardiovascular Diseases - epidemiology | Hypertension - complications | Adult | Female | Hypercholesterolemia - complications | Stroke - epidemiology | Diabetes Mellitus, Type 2 - complications | Cohort Studies | Diabetics | Cardiovascular diseases | Health aspects | Patient outcomes | Risk factors | Myocardial infarction | Cardiac arrhythmia | Heart attacks | Cardiovascular disease | Confidence intervals | Smoking cessation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Heart diseases | Age | Heart failure | Cerebral infarction | Stroke | Mortality | Diabetes mellitus | Patients | Low density lipoprotein | Cholesterol | Death | Diabetes | Health risk assessment | Smoking | microvascular | disease | complications | mellitus | association | Klinisk medicin | multifactorial intervention | Clinical Medicine | follow-up | hyperglycemia | outcomes | management | accord randomized-trial | General & Internal Medicine
Journal Article
Best Practice & Research Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2013, Volume 27, Issue 4, pp. 501 - 507
Journal Article